BeOne Medicines Ltd. (ONC)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$298.74
-0.05%
Mkt Cap $32.30B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $1.47B | $1.50B | +2.24% | $1.60 | $0.58 | -63.75% | — | — |
| Q4 2025 Nov 6, 2025 | $1.45B | $1.41B | -2.72% | $0.72 | $1.09 | +51.39% | — | — |
| Q3 2025 Aug 6, 2025 | $1.44B | $1.32B | -8.82% | $0.48 | $0.84 | +75.00% | — | — |
| Q2 2025 May 7, 2025 | $1.25B | $1.12B | -10.36% | -$0.71 | $1.22 | +271.83% | — | — |
| Q1 2025 Feb 27, 2025 | $1.04B | $1.13B | +8.53% | -$0.88 | -$1.43 | -62.50% | — | — |
| Q4 2024 Nov 12, 2024 | — | $1.00B | — | -$0.88 | -$1.15 | -30.68% | — | — |
| Q3 2024 Aug 7, 2024 | — | $929.17M | — | -$2.10 | -$1.15 | +45.24% | — | — |
| Q1 2024 Mar 31, 2024 | — | $751.65M | — | — | -$2.41 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | $634.41M | — | — | -$25.53 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | $781.31M | — | — | $2.01 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $595.26M | — | — | -$3.64 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | $447.80M | — | — | -$3.34 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $380.10M | — | — | -$30.54 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | $387.63M | — | — | -$5.39 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $341.57M | — | — | -$5.56 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | $306.63M | — | — | -$4.24 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | $213.98M | — | — | -$6.16 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $206.44M | — | — | -$4.46 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $149.99M | — | — | -$5.23 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $605.87M | — | — | $0.69 | — | — | — |